Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,548 | 968 | 1,151 | 2,703 | 7,258 |
| Marketable Securities | 80 | 2,000 | 3,850 | 5,098 | 5,081 |
| Receivables | 175 | 226 | 241 | 264 | 133 |
| Inventories | 5,478 | 5,156 | 6,684 | 6,523 | 4,245 |
| Other current assets | 3,236 | 3,071 | 1,761 | 1,414 | 1,040 |
| TOTAL | $23,517 | $11,421 | $13,687 | $16,002 | $17,757 |
| Non-Current Assets | |||||
| PPE Net | 10,840 | 10,968 | 10,906 | 10,603 | 9,780 |
| Investments And Advances | 12 | 261 | 261 | 260 | 11 |
| Intangibles | 407 | 384 | 344 | 275 | 252 |
| Other Non-Current Assets | 1,091 | 1,129 | 1,148 | 1,159 | 1,184 |
| TOTAL | $12,350 | $12,742 | $12,659 | $12,297 | $11,227 |
| Total Assets | $35,867 | $24,163 | $26,346 | $28,299 | $28,984 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 304 | 252 | 196 | N/A | 50 |
| Accounts payable and accrued liabilities | 476 | 875 | 975 | 1,099 | 762 |
| Accrued Expenses | 1,588 | 791 | 727 | 1,220 | 1,134 |
| TOTAL | $2,368 | $1,918 | $1,898 | $2,319 | $1,946 |
| Non-Current Liabilities | |||||
| Long Term Debt | 276 | 328 | 384 | 630 | N/A |
| Other Non-Current Liabilities | 420 | 445 | 466 | 487 | 501 |
| TOTAL | $696 | $773 | $850 | $1,117 | $501 |
| Total Liabilities | $3,064 | $2,691 | $2,748 | $3,436 | $2,447 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,327 | 45,366 | 41,304 | 41,196 | 41,186 |
| Common Shares | 109,720 | 95,427 | 95,270 | 95,020 | 94,754 |
| Retained earnings | -74,143 | -71,229 | -68,906 | -67,249 | -65,367 |
| Other shareholders' equity | -2,774 | -2,726 | -2,766 | -2,908 | -2,850 |
| TOTAL | $32,803 | $21,472 | $23,598 | $24,863 | $26,537 |
| Total Liabilities And Equity | $35,867 | $24,163 | $26,346 | $28,299 | $28,984 |